SEARCH

SEARCH BY CITATION

References

  • 1
    Davignon J., Ganz P., Role of endothelial dysfunction in atherosclerosis, Circulation, 109: 2732, 2004.
  • 2
    Dignat-George F., Sampol J., Circulating endothelial cells in vascular disorders: new insights into an old concept, Eur. J. Haematol., 65: 215220, 2000.
  • 3
    Carmeliet P., Angiogenesis in health and disease, Nat. Med., 9: 653660, 2003.
  • 4
    Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M., Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275: 964967, 1997.
  • 5
    Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., Moore M.A., Rafii S., Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors, Blood, 95: 952958, 2000.
  • 6
    Gehling U.M., Ergün S., Schumacher U., Wagener C., Pantel K., Otte M., Schuch G., Schafhausen P., Mende T., Kilic N., Kluge K., Schafer B., Hossfeld D.K., Fiedler W., in vitro differentiation of endothelial cells from AC133-positive progenitor cells, Blood, 95: 31063112, 2000.
  • 7
    Quirici N., Soligo D., Caneva L., Servida F., Bossolasco P., Deliliers G.L., Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells, Br. J. Haematol., 115: 186194, 2001.
  • 8
    Hristov M., Erl W., Weber P.C., Endothelial progenitor cells: mobilization, differentiation, and homing, Arterioscler. Thromb. Vasc. Biol., 23: 11851189, 2003.
  • 9
    Yin A.H., Miraglia S., Zanjani E.D., Almeida-Porada G., Ogawa M., Leary A.G., Olweus J., Kearney J., Buck D.W., AC133, a novel marker for human hematopoietic stem and progenitor cells, Blood, 90: 50025012, 1997.
  • 10
    Gulati R., Jevremovic D., Peterson T.E., Chatterjee S., Shah V., Vile R.G., Simari R.D., Diverse origin and function of cells with endothelial phenotype obtained from adult human blood, Circ. Res., 93: 10231025, 2003.
  • 11
    Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P., Origins of circulating endothelial cells and endothelial outgrowth from blood, J. Clin. Invest., 105: 7177, 2000.
  • 12
    Rehman J., Li J., Orschell C.M., March K.L., Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors, Circulation, 107: 11641169, 2003.
  • 13
    Harraz M., Jiao C., Hanlon H.D., Hartley R.S., Schatteman G.C., CD34- blood-derived human endothelial cell progenitors, Stem Cells, 19: 304312, 2001.
  • 14
    Fujiyama S., Amano K., Uehira K., Yoshida M., Nishiwaki Y., Nozawa Y., Jin D., Takai S., Miyazaki M., Egashira K., Imada T., Iwasaka T., Matsubara H., Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells, Circ. Res., 93: 980989, 2003.
  • 15
    Zhao Y., Glesne D., Huberman E., A human peripheral blood monocyte-derived subset acts as pluripotent stem cells, Proc. Natl. Acad. Sci. USA., 100: 24262431, 2003.
  • 16
    Schmeisser A., Garlichs C.D., Zhang H., Eskafi S., Graffy C., Ludwig J., Strasser R.H., Daniel W.G., Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions, Cardiovasc. Res., 49: 671680. 2001.
  • 17
    Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M., Dimmeler S., Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells, Circulation, 108: 2511256, 2003.
  • 18
    Ribatti D., Vacca A., Nico B., Ria R., Dammacco F., Cross-talk between hematopoiesis and angiogenesis signaling pathways, Curr. Mol. Med., 2: 537543, 2002.
  • 19
    Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T., Circulating endothelial progenitor cells, vascular function, and cardiovascular risk, N. Engl. J. Med., 348: 593600, 2003.
  • 20
    Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R., Crystal R.G., Besmer P., Lyden D., Moore M.A., Werb Z., Rafii S., Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand, Cell, 109: 625637, 2002.
  • 21
    Aicher A., Heeschen C., Mildner-Rihm C., Urbich C., Ihling C., Technau-Ihling K., Zeiher A.M., Dimmeler S., Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells, Nat. Med., 9: 13701376, 2003.
  • 22
    Hristov M., Erl W., Linder S., Weber P.C., Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro, Blood, 104: 27612766, 2004.
  • 23
    Strehlow K., Werner N., Berweiler J., Link A., Dirnagl U., Priller J., Laufs K., Ghaeni L., Milosevic M., Bohm M., Nickenig G., Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation, Circulation, 107: 30593065, 2003.
  • 24
    Adams V., Lenk K., Linke A., Lenz D., Erbs S., Sandri M., Tarnok A., Gielen S., Emmrich F., Schuler G., Hambrecht R., Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia, Arterioscler Thromb Vasc Biol., 24: 684690, 2004.
  • 25
    Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., Dimmeler S., Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease, Circ Res. 89: e1e7, 2001.
  • 26
    Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., Levine J.P., Gurtner G.C., Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures, Circulation, 106: 27812786, 2002.
  • 27
    Loomans C.J., de Koning E.J., Staal F.J., Rookmaaker M.B., Verseyden C., de Boer H.C., Verhaar M.C., Braam B., Rabelink T.J., van Zonneveld A.J., Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes, Diabetes, 53: 195199, 2004.
  • 28
    Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., Sasaki K., Shimada T., Oike Y., Imaizumi T., Mobilization of endothelial progenitor cells in patients with acute myocardial infarction, Circulation, 103: 27762779, 2001.
  • 29
    Gill M., Dias S., Hattori K., Rivera M.L., Hicklin D., Witte L., Girardi L., Yurt R., Himel H., Rafii S., Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells, Circ. Res., 88: 167174, 2001.
  • 30
    Valgimigli M., Rigolin G.M., Fucili A., Della Porta M., Soukhomovskaia O., Malagutti P., Bugli A.M., Bragotti L.Z., Francolini G., Mauro E., Castoldi G., Ferrari R., CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure, Circulation, 110: 12091212, 2004.
  • 31
    Llevadot J., Murasawa S., Kureishi Y., Uchida S., Masuda H., Kawamoto A., Walsh K., Isner J.M., Asahara T., HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells, J. Clin. Invest., 108: 399405, 2001.
  • 32
    Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., Nishimura H., Losordo D.W., Asahara T., Isner J.M., Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells, Circulation, 105: 30173024, 2002.
  • 33
    Werner N., Priller J., Laufs U., Endres M., Bohm M., Dirnagl U., Nickenig G., Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointima formation: effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition, Arterioscler. Thromb. Vasc. Biol., 22: 15671572, 2002.
  • 34
    Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., Rutten H., Fichtlscherer S., Martin H., Zeiher A.M., HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway, J. Clin. Invest., 108: 391397, 2001.
  • 35
    Kalka C., Masuda H., Takahashi T., Gordon R., Tepper O., Gravereaux E., Pieczek A., Iwaguro H., Hayashi S.I., Isner J.M., Asahara T., Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects, Circ. Res., 86: 11981202, 2000.
  • 36
    Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., Asahara T., Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization, Nat. Med., 5: 434438, 1999.
  • 37
    Bahlmann F.H., De Groot K., Spandau J.M., Landry A.L., Hertel B., Duckert T., Boehm S.M., Menne J., Haller H., Fliser D., Erythropoietin regulates endothelial progenitor cells, Blood, 103: 921926, 2004.
  • 38
    Weber C., Schober A., Zernecke A., Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease, Arterioscler. Thromb. Vasc. Biol., 24: 19972008, 2004.
  • 39
    Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., Bosch-Marce M., Masuda H., Losordo D.W., Isner J.M., Asahara T., Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization, Circulation, 107: 13221328, 2003.
  • 40
    Schober A., Knarren S., Lietz M., Lin E.A., Weber C., Crucial role of stromal cell-derived factor-1 alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice, Circulation, 108: 24912497, 2003.
  • 41
    Liehn E.A., Schober A., Weber C., Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in apolipoprotein E-deficient mice, Arterioscler. Thromb. Vasc. Biol., 24: 18911896, 2004.
  • 42
    George J., Herz I., Goldstein E., Abashidze S., Deutch V., Finkelstein A., Michowitz Y., Miller H., Keren G., Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis, Arterioscler. Thromb. Vasc. Biol. 23: e5760, 2003.
  • 43
    Iwaguro H., Yamaguchi J., Kalka C., Murasawa S., Masuda H., Hayashi S., Silver M., Li T., Isner J.M., Asahara T., Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration, Circulation, 105: 732738, 2002.
  • 44
    Kalka C., Tehrani H., Laudenberg B., Vale P.R., Isner J.M., Asahara T., Symes J.F., VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease, Ann. Thorac. Surg., 70: 829834, 2000.
  • 45
    Hiasa K., Ishibashi M., Ohtani K., Inoue S., Zhao Q., Kitamoto S., Sata M., Ichiki T., Takeshita A., Egashira K., Gene transfer of stromal cell-derived factor-1 alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization, Circulation, 109: 24542461, 2004.
  • 46
    Kawamoto A., Gwon H.C., Iwaguro H., Yamaguchi J.I., Uchida S., Masuda H., Silver M., Ma H., Kearney M., Isner J.M., Asahara T., Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia, Circulation, 103: 634637, 2001.
  • 47
    Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., Itescu S., Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function, Nat. Med., 7: 430436, 2001.
  • 48
    Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., Amano K., Kishimoto Y., Yoshimoto K., Akashi H., Shimada K., Iwasaka T., Imaizumi T., Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial, Lancet, 360: 427435, 2002.
  • 49
    Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., Kogler G., Wernet P., Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans, Circulation, 106: 19131918, 2002.
  • 50
    Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., Grunwald F., Aicher A., Urbich C., Martin H., Hoelzer D., Dimmeler S., Zeiher A.M., Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI), Circulation, 106: 30093017, 2002.
  • 51
    Stamm C., Westphal B., Kleine H.D., Petzsch M., Kittner C., Klinge H., Schumichen C., Nienaber C.A., Freund M., Steinhoff G., Autologous bone-marrow stem-cell transplantation for myocardial regeneration, Lancet, 361: 4546, 2003.
  • 52
    Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., Fichtner S., Korte T., Hornig B., Messinger D., Arseniev L., Hertenstein B., Ganser A., Drexler H., Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial, Lancet, 364: 141148, 2004.
  • 53
    Kang H.J., Kim H.S., Zhang S.Y., Park K.W., Cho H.J., Koo B.K., Kim Y.J., Soo Lee D., Sohn D.W., Han K.S., Oh B.H., Lee M.M., Park Y.B., Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial, Lancet, 363: 751756, 2004.
  • 54
    Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., Pasumarthi K.B., Virag J.I., Bartelmez S.H., Poppa V., Bradford G., Dowell J.D., Williams D.A., Field L.J., Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts, Nature, 428: 664668, 2004.
  • 55
    Kaushal S., Amiel G.E., Guleserian K.J., Shapira O.M., Perry T., Sutherland F.W., Rabkin E., Moran A.M., Schoen F.J., Atala A., Soker S., Bischoff J., Mayer J.E. Jr., Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo, Nat. Med., 7: 10351040, 2001.
  • 56
    Kong D., Melo L.G., Mangi A.A., Zhang L., Lopez-Ilasaca M., Perrella M.A., Liew C.C., Pratt R.E., Dzau V.J., Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells, Circulation, 109: 17691775, 2004.